tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Matthew Sharpe, 27 are a HOLD (43.55%), 4 are a SELL (6.45%), 31 are a BUY (50%).
Analyst Matthew Sharpe works at MORGAN STANLEY with a stock forecast success ratio of 79.03% fulfilled within 180.67 days on average.
Matthew Sharpe’s has documented 129 price targets and ratings displayed on 12 stocks. The coverage is on Industrials, Technology sectors.
Most recent stock forecast was given on PL, Planet Labs PBC at 12-Jun-2023.
Analyst best performing recommendations are on MAXR (MAXAR TECHNOLOGIES).
The best stock recommendation documented was for MAXR (MAXAR TECHNOLOGIES) at 12/14/2022. The price target of $42 was fulfilled within 2 days with a profit of $17.96 (74.71%) receiving and performance score of 373.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
136
$-7.01 (-4.90%)
104
2 months 18 days ago
2/3 (66.67%)
$-7.54 (-5.25%)
164
Hold
158
$14.99 (10.48%)
138
2 months 25 days ago
10/11 (90.91%)
$13.83 (9.59%)
200
Hold
145
$1.99 (1.39%)
120
2 months 26 days ago
11/11 (100%)
$1.11 (0.77%)
151
Buy
158
$14.99 (10.48%)
102
2 months 26 days ago
2/3 (66.67%)
$14.11 (9.81%)
224
Sell
125
3 months 19 days ago
6/6 (100%)
$5.26 (4.39%)
158
What Year was the first public recommendation made by Matthew Sharpe?
